The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule

被引:133
作者
Vartdal, F
Johansen, BH
Friede, T
Thorpe, CJ
Stevanovic, S
Eriksen, JE
Sletten, K
Thorsby, E
Rammensee, HG
Sollid, LM
机构
[1] NATL HOSP NORWAY,RIKSHOSP,INST TRANSPLANTAT IMMUNOL,OSLO,NORWAY
[2] DEUTSCH KREBSFORSCHUNGSZENTRUM,DEPT IMMUNOL,D-6900 HEIDELBERG,GERMANY
[3] UNIV LONDON BIRKBECK COLL,DEPT CRYSTALLOG,LONDON,ENGLAND
[4] NORSK HYDRO AS,RES CTR,DEPT MED & ORGAN CHEM,N-3901 PORSGRUNN,NORWAY
[5] UNIV OSLO,DEPT BIOCHEM,OSLO,NORWAY
[6] BIOTECHNOL CTR OSLO,OSLO,NORWAY
关键词
HLA; DQ2; binding motif; anchor residue; pocket; autoimmune disease;
D O I
10.1002/eji.1830261132
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To identify the binding motifs of peptides which bind to the celiac disease and insulin-dependent-diabetes-mellitus (IDDM)-associated DQ2 molecule, peptides tides were eluted from affinity-purified DQ2 molecules. The eluted peptides were separated by reverse-phase HPLC. Prominent peptide peaks and the remaining pool of peptides were sequenced by Edman degradation. Truncated variants of eight different peptides with a length of 9-19 amino acids were identified; among them class II-associated invariant chain peptides (CLIP) and peptides that stem from HLA class I alpha, HLA-DQ alpha 1*0501, Ig and CD20 molecules. Data from the pool sequencing and the biochemical binding analyses of synthetic variants of an eluted high-affinity ligand (HLA class I alpha 46-60), indicate that the side chains of amino acid residues at relative position P1 (bulky hydrophobic), P4 (negatively charged or aliphatic), P6 (Pro or negatively charged), P7 (negatively charged) and P9 (bulky hydrophobic) are important for binding of peptides to DQ2. Computer modeling of the DQ2 with variants of the high-affinity ligand in the groove suggests that peptides bind to DQ2 through the primary anchors P1, P7 and P9 and making additional advantageous interactions using the P4 and P6 positions.
引用
收藏
页码:2764 / 2772
页数:9
相关论文
共 24 条
[1]   RECEPTOR-LIGAND INTERACTIONS MEASURED BY AN IMPROVED SPUN COLUMN CHROMATOGRAPHY TECHNIQUE - A HIGH-EFFICIENCY AND HIGH-THROUGHPUT SIZE SEPARATION METHOD [J].
BUUS, S ;
STRYHN, A ;
WINTHER, K ;
KIRKBY, N ;
PEDERSEN, LO .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1995, 1243 (03) :453-460
[2]   SELF-PEPTIDES BOUND TO THE TYPE-I DIABETES-ASSOCIATED CLASS-II MHC MOLECULES HLA-DQ1 AND HLA-DQ8 [J].
CHICZ, RM ;
LANE, WS ;
ROBINSON, RA ;
TRUCCO, M ;
STROMINGER, JL ;
GORGA, JC .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (11) :1639-1649
[3]   PREDOMINANT NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR1 ARE DERIVED FROM MHC-RELATED MOLECULES AND ARE HETEROGENEOUS IN SIZE [J].
CHICZ, RM ;
URBAN, RG ;
LANE, WS ;
GORGA, JC ;
STERN, LJ ;
VIGNALI, DAA ;
STROMINGER, JL .
NATURE, 1992, 358 (6389) :764-768
[4]  
FALK K, 1994, IMMUNOGENETICS, V39, P230
[5]   THE STRUCTURE OF AN INTERMEDIATE IN CLASS-II MHC MATURATION - CLIP BOUND TO HLA-DR3 [J].
GHOSH, P ;
AMAYA, M ;
MELLINS, E ;
WILEY, DC .
NATURE, 1995, 378 (6556) :457-462
[6]   PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY [J].
GREENWOOD, FC ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1963, 89 (01) :114-&
[7]   IDENTIFICATION OF A MOTIF FOR HLA-DR1 BINDING PEPTIDES USING M13 DISPLAY LIBRARIES [J].
HAMMER, J ;
TAKACS, B ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1007-1013
[8]   PRECISE PREDICTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PEPTIDE INTERACTION BASED ON PEPTIDE SIDE-CHAIN SCANNING [J].
HAMMER, J ;
BONO, E ;
GALLAZZI, F ;
BELUNIS, C ;
NAGY, Z ;
SINIGAGLIA, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2353-2358
[9]   Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides [J].
Jardetzky, TS ;
Brown, JH ;
Gorga, JC ;
Stern, LJ ;
Urban, RG ;
Strominger, JL ;
Wiley, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :734-738
[10]   Identification of a putative motif for binding of peptides to HLA-DQ2 [J].
Johansen, BH ;
Vartdal, F ;
Eriksen, JA ;
Thorsby, E ;
Sollid, LM .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (02) :177-182